Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials
M. Aboulghar et al., Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials, FERT STERIL, 75(1), 2001, pp. 88-91
Objective: To investigate the optimum number of cycles of controlled ovaria
n hyperstimulation and intrauterine insemination in the treatment of unexpl
ained infertility.
Design: Observational prospective study.
Setting: In vitro fertilization embryo transfer center.
Patient(s): Five hundred ninety-four couples with unexplained infertility.
Intervention(s): Controlled ovarian hyperstimulation (COH), intrauterine in
semination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm
injection (ICSI).
Main Outcome Measure(s): Cycle fecundity.
Result(s): One to 3 cycles of COH/IUI were performed in 594 patients (group
A) undergoing 1,112 cycles (mean, 1.9 cycles/patient). Up to 3 further tri
als (cycles 4-6) of COH/IUI were then performed in 91 of these women (group
B), a total of 161 cycles (mean, 1.8 cycles/patient). A historical compari
son group C consisted of 131 patients with 3 failed cycles of COH/IUI who u
nderwent 1 cycle of IVF and ICSI at our center. In group A, 182 pregnancies
occurred, with a cycle fecundity of 16.4% and a cumulative pregnancy rate
(PR) of 39.2% after the first 3 cycles. In group B, 9 pregnancies occurred
in cycles 4-6, with a cycle fecundity of 5.6%, significantly lower than tha
t of group A (P<.001). The cumulative PR rose to 48.5% by cycle 6, a furthe
r increase of only 9.3%. In the women undergoing IVF and ICSI in group C, 4
8 pregnancies occurred, with a cycle fecundity of 36.6% per cycle, signific
antly higher than that of group B (P<.001).
Conclusion(s): in unexplained infertility, the cycle fecundity in the first
three trials of COH and IUI was higher than in cycles 4-6, with a statisti
cally significant difference. Patients should be offered IVF or ICSI if the
y fail to conceive after three trials of COH and IUI. (C) 2001 by American
Society for Reproductive Medicine.